St. Olavs Hospital HF

At St. Olavs Hospital HF, the Rheumatology department contributes to research in hematologic cancers and related blood disorders, with trials focused on follicular lymphoma and diffuse large B-cell lymphoma. These studies are designed to evaluate how well new treatment approaches control disease and improve outcomes for patients with relapsed or difficult-to-treat lymphoma.

• Testing new therapy options for follicular lymphoma
• Comparing treatment effectiveness in diffuse large B-cell lymphoma
• Studying approaches for early relapse and refractory disease

The site’s work in this area reflects a strong interest in finding better ways to manage lymphatic system cancers and support patients whose disease returns after initial treatment.

Research in musculoskeletal diseases centers on osteoarthritis, especially painful inflammatory disease in the first carpometacarpal joint. These trials aim to compare symptom relief strategies and improve everyday function for people living with hand arthritis.

• Evaluating treatments for painful inflammatory osteoarthritis
• Comparing intraarticular corticosteroid care with other supportive options
• Assessing non-drug rehabilitation approaches for joint pain

This work at St. Olavs Hospital HF highlights a practical focus on easing pain, preserving mobility, and identifying the most effective care for common joint disorders.

Within the broader field of neoplasms, the site is involved in trials for non-small cell lung cancer and atypical teratoid/rhabdoid tumours. The research includes efforts to test new cancer therapies and to improve survival outcomes in both adult and pediatric oncology.

• Investigating treatment effectiveness in non-small cell lung cancer
• Studying consolidation strategies for atypical teratoid/rhabdoid tumours
• Exploring better ways to improve survival in aggressive cancers

These studies show an interest in both solid tumors and rare childhood cancers, with a clear goal of advancing more effective cancer care.

The site also supports research in nervous system diseases, with a strong emphasis on migraine and chronic migraine. The trials are aimed at confirming whether preventive treatment strategies can reduce headache burden and improve daily life for people affected by recurrent migraines.

• Studying prevention for chronic migraine
• Evaluating treatment options for episodic migraine
• Measuring the impact of therapies on headache frequency and symptom control

This area of research focuses on better long-term management of migraine disorders, an important need for patients with frequent or disabling headaches.

In virus diseases, clinical trials at St. Olavs Hospital HF address COVID-19 and mpox virus disease. The studies examine whether antiviral or immune-targeted treatments can improve recovery, reduce complications, and support hospitalized patients with active infection.

• Evaluating treatment effectiveness in SARS-CoV-2 infection
• Assessing care strategies for hospitalized patients with moderate and severe COVID-19
• Describing outcomes in mpox virus disease with and without antiviral treatment

This infectious disease research reflects a focus on improving care during outbreaks and identifying therapies that may lessen the impact of serious viral illness.